Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone Addition for Luteal Phase Support in IVF
NCT04408144Unknown
- Sponsor
- Laniado Medical Center
- Start
- Apr 2022
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of dydrogesterone in infertility (2 arms), sponsored by Laniado Medical Center. Primary endpoint: Live birth rate at 9 months. Status: unknown.
02
Drugs
dydrogesterone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT04408144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04408144.